The page lists 42 projects related to the topic "als".
# | |||
---|---|---|---|
1 | MIROCALS | Efficacy and safety of low-dose IL-2 (ld-IL-2) as a Treg enhancer for anti-neuroinflammatory therapy in newly diagnosed Amyotrophic Lateral Sclerosis (ALS) patients | 2015 |
2 | CorticALS | Amyotrophic Lateral Sclerosis from a cortical perspective: towards alternative therapeutic strategies | 2015 |
3 | THALAMODEL | Multimodal, high-resolution modeling of the thalamus for neuroimaging studies: application to dyslexia | 2015 |
4 | LORENZLIDAR | Classification of Forest Structural Types with LiDAR Remote Sensing Applied to Study Tree Size-Density Scaling Theories | 2016 |
5 | Als-on-a-chip | A tissue-on-a-chip platform for systems-level studies of ALS pathology and drug screening | 2015 |
6 | CONTESSA | COuNt data TimE SerieS Analysis: significance tests and sequencing data application | 2015 |
7 | NMJALS | In vivo analysis of neuromuscular junction stability in zebrafish models of amyotrophic lateral sclerosis | 2015 |
8 | DEALS | Biomarker assay development to expedite ALS experimental therapeutic advancement | 2015 |
9 | C9ND | C9orf72-mediated neurodegeneration: mechanisms and therapeutics | 2015 |
10 | SIDSCA | Defective DNA Damage Responses in Dominant Neurodegenerative Diseases | 2016 |
11 | IntegraMouse3 | Next-generation, modular computer mouse device for disabled people | 2016 |
12 | ALS-Networks | Defining functional networks of genetic causes for ALS and related neurodegenerative disorders | 2017 |
13 | NanoALS | Nanoparticle-based immunization, a novel therapeutic strategy for amyotrophic lateral sclerosis | 2018 |
14 | ExItALS | RNA-mediated intercellular miscommunication: role of extracellular vesicle cargos in Amyotrophic Lateral Sclerosis | 2017 |
15 | PhaseAge | The chemistry and physics of RNP granules: how they form, age and cause disease | 2017 |
16 | NanoZfish | Restoration of motor dysfunction in vivo through nanomaterials based devices | 2017 |
17 | CORFEDITING | Gene Editing as Therapeutic Strategy for C9ORF72 Linked ALS/FTD | 2017 |
18 | INDTECH2018 | INDustrial TECHnologies 2018 - innovative industries for smart growth | 2017 |
19 | EuroNeurotrophin | A European training network for the discovery of neurotrophins small molecule mimetics as candidate therapeutic agents for neurodegeneration and neuroinflammation | 2018 |
20 | EU-LISTCO | Europe's External Action and the Dual Challenges of Limited Statehood and Contested Orders | 2018 |
21 | AUTOIGG | AUTOMATED FUNCTIONAL SCREENING OF IgGs FOR DIAGNOSTICS OF NEURODEGENERATIVE DISEASES | 2018 |
22 | TUDCA-ALS | Safety and efficacy of tauroursodeoxycholic acid (TUDCA) as add-on treatment in patients affected by amyotrophic lateral sclerosis (ALS) | 2018 |
23 | DeepRNA | Discovering functional protein-RNA interactions through data integration and machine learning. | 2018 |
24 | eyecontrol | EyeControl | 2018 |
25 | CRISPR-GQ | Identifying the Capabilities and Limitations of CRISPR in Targeting G-quadruplex Forming Sequences: From Target Recognition to Gene Expression Regulation | 2018 |
26 | EScORIAL | Emerging Simplex ORigins In ALS | 2018 |
27 | Spectro-Metrics | Advanced Data Mining Procedures Applied to Raman Spectroscopy Investigations of Interactions between Drugs and Cells. | 2018 |
28 | NeuroRBP | Studying RNA-binding proteins involved in neural differentiation and degeneration | 2019 |
29 | MAPSYNE | Miniaturized automated patch-clamp system combined with high-density microelectrode arrays for multi-scale functional mapping of neuronal networks | 2018 |
30 | ALS2 | AcidLess Separation 2.0 | 2018 |
31 | NeuroProtect | Novel Drug Therapy with Potential to Cure Neuro-Degenerative Diseases | 2018 |
32 | Combat_ALS | Development of new chemical tools to combat ALS | 2019 |
33 | MegaALS | Unravelling the Interplay between Metabolism, Gut Microbiome and Adaptive Immunity in Amyotrophic Lateral Sclerosis | 2018 |
34 | Neurovulnerability | Molecular mechanisms underlying selective neuronal death in motor neuron diseases | 2019 |
35 | FutureTrophicFactors | Elucidating therapeutic effects and mode of action of future trophic factorsin ALS and Parkinson’s disease | 2019 |
36 | StressOME | Defining and modulating the stress granule proteome as a therapeutic strategy in Amyotrophic Lateral Sclerosis | 2019 |
37 | MOVEMeNt | Decoding alpha motor neurons diversity and selective vulnerability to disease | 2020 |
38 | MetALS | Investigating the pharmacokinetic properties of toxic metals and heat shock proteins as risk factors in Amyotrophic Lateral Sclerosis | 2019 |
39 | HominAb | Discovering novel antibodies derived from the human body itself to treat neurodegenerative diseases | 2019 |
40 | NeuroPa | Targeting the brain sigma-1 receptor: A paradigm shift for the treatment of neuro-degenerative disorders | 2019 |
41 | RNPdynamics | Multivalent interactions driving RNP dynamics in development and disease | 2020 |
42 | DPR-VAX | Dipeptide-Repeat Vaccine to prevent ALS and FTD in C9orf72 mutation carriers | 2020 |